Literature DB >> 11584468

Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome.

M Alings1, L Dekker, A Sadée, A Wilde.   

Abstract

Two patients with Brugada syndrome are presented. The ECGs showed right precordial J waves and ST-segment elevation. Patient 1 was resuscitated from nocturnal ventricular fibrillation, patient 2 was asymptomatic. In only patient 1, flecainide was infused causing monomorphic "malignant" ventricular extrasystoles (R on T), demonstrating the deleterious effect of Class IC antiarrhythmic drugs in Brugada syndrome. However, administration of the Class Ia antiarrhythmic drug quinidine caused normalization of the ECG in both patients. Based on in vitro experiments, agents that reduce the magnitude of Ito-mediated phase 1 have been suggested to normalize ST-segment elevation in Brugada syndrome. This is the first clinical report of such a quinidine induced ECG normalization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584468     DOI: 10.1046/j.1460-9592.2001.01420.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  42 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Link between hypothermia and the Brugada syndrome.

Authors:  Jeffrey M Fish; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2004-08

3.  In vivo human demonstration of phase 2 reentry.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2005-08       Impact factor: 6.343

Review 4.  Brugada syndrome in childhood: a potential fatal arrhythmia not always recognised by paediatricians. A case report and review of the literature.

Authors:  Yvan Mivelaz; Stefano Di Bernardo; Etienne Pruvot; Erik Jan Meijboom; Nicole Sekarski
Journal:  Eur J Pediatr       Date:  2006-05-03       Impact factor: 3.183

Review 5.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 6.  Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel.

Authors:  Carlo Napolitano; Charles Antzelevitch
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

Review 7.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 8.  Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

Authors:  Ilan Goldenberg; Arthur J Moss; Wojciech Zareba
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

9.  Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.

Authors:  Yoshino Minoura; Brian K Panama; Vladislav V Nesterenko; Matthew Betzenhauser; Hector Barajas-Martínez; Dan Hu; José M Di Diego; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2013-03-14       Impact factor: 6.343

Review 10.  Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

Authors:  Ijaz A Khan; Chandra K Nair
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.